Journey Medical Corp
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a top… Read more
Market Cap & Net Worth: Journey Medical Corp (DERM)
Journey Medical Corp (NASDAQ:DERM) has a market capitalization of $204.42 Million ($204.42 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17210 globally and #6548 in its home market, demonstrating a -6.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Journey Medical Corp's stock price $7.50 by its total outstanding shares 27256588 (27.26 Million).
Journey Medical Corp Market Cap History: 2021 to 2026
Journey Medical Corp's market capitalization history from 2021 to 2026. Data shows change from $146.64 Million to $204.42 Million (-5.29% CAGR).
Index Memberships
Journey Medical Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #469 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1609 of 3165 |
Weight: Journey Medical Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Journey Medical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Journey Medical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.90x
Journey Medical Corp's market cap is 1.90 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $146.64 Million | $63.13 Million | -$43.99 Million | 2.32x | N/A |
| 2022 | $52.33 Million | $73.67 Million | -$29.63 Million | 0.71x | N/A |
| 2023 | $157.00 Million | $79.18 Million | -$3.85 Million | 1.98x | N/A |
| 2024 | $106.57 Million | $56.13 Million | -$14.67 Million | 1.90x | N/A |
Competitor Companies of DERM by Market Capitalization
Companies near Journey Medical Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Journey Medical Corp by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Journey Medical Corp Historical Marketcap From 2021 to 2026
Between 2021 and today, Journey Medical Corp's market cap moved from $146.64 Million to $ 204.42 Million, with a yearly change of -5.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $204.42 Million | -2.72% |
| 2025 | $210.15 Million | +97.19% |
| 2024 | $106.57 Million | -32.12% |
| 2023 | $157.00 Million | +200.00% |
| 2022 | $52.33 Million | -64.31% |
| 2021 | $146.64 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Journey Medical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $204.42 Million USD |
| MoneyControl | $204.42 Million USD |
| MarketWatch | $204.42 Million USD |
| marketcap.company | $204.42 Million USD |
| Reuters | $204.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.